SCHEMBL18471609

SCHEMBL18471609

NCCN1C(=O)CC(N)C1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.36
ALDH1A1 P00352 3/20 0.35
HTT P42858 2/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
AADAT Q8N5Z0 5/20 0.31
HEXA P06865 1/20 0.31
HEXB P07686 1/20 0.31
GOT1 P17174 1/20 0.30
KYAT1 Q16773 1/20 0.30
KYAT3 Q6YP21 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2853911 0.82 LMNA (0.36) CYP19A1ALDH1A1HTTTP53MAPT
SCHEMBL2853909 0.82 LMNA (0.36) CYP19A1ALDH1A1HTTTP53MAPT
SCHEMBL14275616 0.82 CYP19A1 (0.53) CYP19A1ALDH1A1HTTTP53MAPT
Bromide SCHEMBL20548193 0.80 LMNA (0.35) CYP19A1ALDH1A1HTTTP53MAPT
SCHEMBL24795973 0.78 CYP19A1 (0.35) CYP19A1ALDH1A1HTTGAAMAPK1
SCHEMBL21384020 0.78 CYP19A1 (0.35) CYP19A1ALDH1A1HTTGAAMAPK1
SCHEMBL17614238 0.78 CYP19A1 (0.38) CYP19A1ALDH1A1HTTGAAMAPK1
SCHEMBL18362386 0.78 CYP19A1 (0.38) CYP19A1
SCHEMBL2687595 0.77 GAA (0.38) CYP19A1ALDH1A1HTTTP53MAPT
SCHEMBL2848946 0.77 GAA (0.38) CYP19A1ALDH1A1HTTTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023118599-A1 IMPLANTABLE DEVICE COMPRISING A HYDROGEL ADOCIA (FR) 2023-06-29 WO disclosed
WO-2022148887-A1 HYDROGELS FOR CELL THERAPY ADOCIA (FR) 2022-07-14 WO disclosed
EP-2813567-B1 C-terminally tethered amino acids and their fibrinolytic therapeutic uses CANADIAN BLOOD SERVICES (CA) 2017-02-08 EP disclosed